Application Filings and Examiner Production. UPR Applications Filed 0 50000 100000 150000 200000 250000 300000 350000 400000 19951996199719981999200020012002200320042005.

Slides:



Advertisements
Similar presentations
TC 1600 Biotechnology and Pharmaceutical Customer Partnership Meeting John Doll - Commissioner for Patents November 10, 2005.
Advertisements

Daphne C. Lainson Smart & Biggar/Fetherstonhaugh Overview of USPTO Patent Statistics.
Accelerating Patent Prosecution Thursday, October 18, 2012.
1 1 1 AIPLA American Intellectual Property Law Association USPTO Updates Including Glossary Pilot Program Chris Fildes Fildes & Outland, P.C. IP Practice.
PROSECUTION APPEALS Presented at: Webb & Co. Rehovot, Israel Date: February 14, 2013 Presented by: Roy D. Gross Associate St. Onge Steward Johnston & Reens.
Robert M. Hansen The Marbury Law Group PLLC AIPLA Practical Patent Prosecution Training for New Lawyers August 2009Alexandria, VA Issuance, Term, Certificates.
Appeal Practice Before Board of Patent Appeals and Interferences
1 Clearing the Oldest Patent Applications (COPA) John Barlow Subject Matter Expert Technology Center 2800.
TC1600 Appeals Practice Jean Witz, Appeals Specialist.
1 Patent Operations: Updates & Highlights Austin Intellectual Property Law Association Austin, TX March 23, 2010.
July 8, Enhanced Examination Timing Control Robert A. Clarke Deputy Director Office of Patent Legal Administration
Accelerated Examination Bennett Celsa (TC 1600: QAS)
Proposed Rule Changes to Focus the Patent Process Involving Continuations, Double Patenting and Claims Connecticut Intellectual Property Law Association.
The United States Patent and Trademark Office March 15, 2005 BCP Customer Partnership Meeting.
THE STATE OF THE PATENT SYSTEM BACKGROUND FOR RULE PROPOSALS Los Angeles Intellectual Property Law Association “Washington and the West” Conference January.
The United States Patent and Trademark Office July 19, 2005 The National Association of Patent Practitioners 2005 Patent Practice Update.
John Doll – Commissioner for Patents February 1, 2006.
Patent Term Adjustment (Bio/Chem. Partnership) Kery Fries, Sr. Legal Advisor Phone: (571)
Green Technology Petition Pilot Robert W. Bahr. 2 Green Tech: Discussion Points 1. Authority and Overview: resources / overview 2.Petition Requirement:
Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy.
Patent Quality Assurance Program. 2 Office of Patent Quality Assurance (OPQA) Deputy Commissioner for Patent Operations Office of Patent Quality Assurance.
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
Food Stamp Program Quality Control Northern Counties Corrective Action Conference September 2007.
General Information on Patents and the Patent Process presented to North American Association of State and Provincial Lotteries June 24, 2008 Brian Hanlon,
John Doll Commissioner for Patents. 2 USPTO Request for Public Input: Strategic Planning  Agency developing new strategic plan  Part of budget process.
July 18, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818/P.L ) Topic: Patent Fees Office of Patent Legal.
December 8, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818)(upon enactment) and 35 U.S.C. 103(c) as Amended by.
The New USPTO Rules and their Impact on Biomedical Patent Prosecution Mojdeh Bahar, J.D.,M.A. Technology Licensing Specialist Office of Technology Transfer.
A View from Both Worlds: USPTO and the Federal Labs Mojdeh Bahar, J.D.,M.A. Technology Licensing Specialist Office of Technology Transfer National Institutes.
1 PPAC Patents Operations Update June 18th, 2009.
1 1 Interview Practice Within the USPTO. 2 2 Topics Effective Interviews Reaching Agreement Requesting Interviews Issues Discussed Documenting Interviews.
Customer Partnership Meeting John Doll Commissioner for Patents.
1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)
1 Biotechnology/Chemical/Pharmaceutical Customer Partnership June 1, 2010 Valencia Martin-Wallace – Director, Technology Center 2400.
1 The CREATE Act and Other Interesting IP Tidbits Brian R. Stanton, Ph.D. Director, Division of Policy Office of Technology Transfer National Institutes.
USPTO Patent Quality Composite presented to Biotechnology/Chemical/Pharmaceutical Customer Partnership September 5, 2012 by Martin Rater Statistician USPTO,
BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. Patent.
1 1 AIPLA American Intellectual Property Law Association Updates on the USPTO Chris Fildes AIPLA-JPAA Joint Meeting April 9, 2013.
After Final Practice Linda M. Saltiel June 2, 2015.
Claims and Continuations Final Rule Overview Briefing for Examiners 1.
USPTO Updated Strategic Plan in Brief March 3 rd, 2010.
Patent Prosecution May PCT- RCE Zombie 371 National Stage PCT Applications –Not Allowed to file an RCE until signed inventor oath/declaration is.
QualityDefinition.PPACMeeting AdlerDraft 1 1 Improving the Quality of Patents Marc Adler PPAC meeting June 18, 2009.
Claims and Continuations Final Rule 1 Joni Y. Chang Senior Legal Advisor Office of Patent Legal Administration (571) ,
FY09 Restriction Petition Update; Comparison of US and National Stage Restriction Practice Julie Burke TC1600 Quality Assurance Specialist
OCFO - Financial Status of USPTO May 7, FY 2010 Status Authorized level of $1,887.0 million Mid-year Budget Execution Review currently underway.
James Toupin – General Counsel February 1, Summary of Proposed Rule Changes to Continuations, Double Patenting, and Claims.
Claims Proposed Rulemaking Main Purposes É Applicant Assistance to Improve Focus of Examination n Narrow scope of initial examination so the examiner is.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
FY 2010 and FY 2011 Budget and Fee Collection Update March 3, 2010.
Andrew B. Freistein Wenderoth, Lind & Ponack, L.L.P. Learning the ABC’s of Patent Term Adjustment 1 © AIPLA 2015.
Bruce Kisliuk Group Director, Technology Center 1600.
“Welcome to the Table” May 15, 2006 Jay Lucas Deputy Commissioner for Patent Examination Policy.
First Action Interview Pilot Program Legal Secretaries & Administrators Conference June 18, 2009.
1 PPAC Patents Operations Update Peggy Focarino Deputy Commissioner for Patents July 8, 2010.
The United States Patent and Trademark Office January 27, 2005.
Board of Patent Appeals and Interferences May 15, Interference Practice Q&A James T. Moore Administrative Patent Judge
1 FY08 Restriction Petition Update and Burden Julie Burke Quality Assurance Specialist Technology Center 1600.
US Patent Application Drafting Center Presentation ppt Patent Stats That Can Help Your Practice Electronic & Computer Law Committee Manny Schecter.
What can patent litigation tell us about patent examination?
Claims and Continuations Final Rule
Examination Time and the Production System
Boston Patent Law Association
RCE Backlog Sample: New case inventories at the end of each fiscal quarter from the fourth quarter of 2009 through August 8, Output: The total number.
TC 1600 Biotechnology and Pharmaceutical Customer Partnership Meeting
First Action Interview Pilot Program
Los Angeles Intellectual Property Law Association
The National Association of Patent Practitioners (NAPP)
Boston Patent Law Association Annual Meeting
Presentation transcript:

Application Filings and Examiner Production

UPR Applications Filed  FY 05 plan 375,080 (5.5% above FY 04)  FY 05 actual 384,228 (8.1% above FY04)  2.6% over plan 9

Production 1 “ UPR” = Utility, Plant, and Reissue Applications. 2 “ FAOM” = First Action on the Merits – first action count by an examiner after the filing of an application (does not include restrictions or other miscellaneous actions). 3 “ Disposal” = An examiner allowance, abandonment, or disposals following a board decision. 4 “ Production Unit” = First action count plus disposal count divided by 2. 5 “ PCT” = Patent Cooperation Treaty. PCT applications are processed differently and tracked separately from US National stage applications. For FY 05, 15,147 PU’s is 35,389 processed applications. 22, , , ,614 FY 05 Target 288,316287,752UPR Production Units 4 15, , ,287 FY 05 16,882PCT Production Units 5 FY ,315UPR 1 FAOM 2 287,188UPR Disposals 3 10

... vs the Backlog PENDENCY

First Action Pendency by Art Areas Pendency 1 (months) 3723 – Tools & Metal Working 3612 – Land Vehicles 2833 – Electrical Connectors 2651 – Dynamic Information Storage & Retrieval 2125 – Manufacturing Control Systems and Chemical/ Mechanical/Electrical Control 1752 – Radiation Imagery 1620 – Heterocyclic Compounds and Uses Low Pendency Art Areas Pendency 1 (months) 3731 – Surgery: Cutting, Clamping, Suturing 3628 – Finance & Banking, Accounting 2836 – Control Circuits 2617 – Interactive Video Distribution 2123 – Simulation and Modeling, Emulation of Computer Components 1743 – Analytic Chemistry & Wave Energy 1640 – Immunology, Receptor/ Ligands, Cytokines, Recombinant Hormones, and Molecular Biology High Pendency Art Areas 1 “Average 1 st action pendency” is the average age from filing to first action for a newly filed application, completed during October-December

Inventory by Art Examples Months of Inventory* 3742 – Thermal and Combustion Technology 3651 – Conveying 2831 – Electrical Conductors 2651, 2653 – Information Storage and Retrieval 2125 – Manufacturing Control Systems and Chemical/ Mechanical/Electrical Control 1734 – Adhesive Bonding and Coating Apparatus 1620 – Organic Chemistry Low Inventory Art Areas Months of Inventory* 3731 and 3737 – Medical Instruments, Diagnostic Equipment 3620 – Business Methods 2836 – Control Circuits 2611 – Interactive Video Distribution 2127 – Computer Task Management 1753 – Radiation Imagery 1614, 1615, and 1617 – Drugs, Bio-affecting and Body Treatment High Inventory Art Areas * The number of months it would take to reach a first action on the merits (e.g., an action addressing patentability issues) on a new application filed in July 2005 at today’s production rate. Today’s production rate means that there are no changes in production due to hiring, attrition, changes to examination processing or examination efficiencies, and that applications are taken up in the order of filing in the given art unit/area. Of course, USPTO is taking aggressive steps to ensure changes that will significantly lower the inventory rates in high-inventory art areas. 13

TC Application Inventory 1 “ New Application inventory” is the number of new applications designated or assigned to a technology center awaiting a first action. 2 “ Overall Pending Application inventory” is the total number of applications designated or assigned to a technology center in an active status. Includes new applications; rejected awaiting response; amended; under appeal or interference; suspended; reexams and allowed applications awaiting grant publication. *Total inventory includes applications not assigned to a particular TC, awaiting processing either pre- or post-examination. 27,599809,323108,039101,097137,458138,822102,440105,44795,006 Overall Pending Applications 2 9/30/ ,451508,87865,00556,73877,65197,38071,77863,92355,402 New Applications 1 9/30/ ,104932,300130,168117,045159,687167,721117,728120,767107,647 Overall Pending Applications 2 9/30/ ,534586,58083,22570,35494,425115,58576,52972,69762,644 New Applications 1 9/30/ Total*Design

Patent Quality (Shared Responsibility)

Quality of Products – FY 05 *Compliance and error rates as measured by OPQA. 1 Compliance is the percent of office actions reviewed and found to be free of any in-process examination deficiency (an error that has significant adverse impact on patent prosecution). 2 Patent allowance error rate is the percent of allowed applications reviewed having at least one claim which is considered unpatentable on a basis for which a court would hold a patent invalid. “Allowance” occurs before a patent is issued, so these errors are caught before any patent is actually granted. 5.32% 82.0% FY 04 Fiscal Year % 86.2% FY % 84.0% FY 05 Target 1.6%6.43%4.94%4.43%2.25%3.56%6.46%4.88% Patent Allowance Error Rate 2* 94.3%86.6%84.4%90.9%84.7%88.1%82.9%81.7% Patent In-Process Examination Compliance Rate 1* 3700Design

Re-Work

Technology Centers Rework* Statistics * Rework first actions are those actions that are in a Continuing (CONs and CIPs), RCE, CPA or 129(a) applications (excludes Divisionals). 18

Hiring and Retention

Hires and Attritions CorpsDesign FY 04 Hires FY 04 Attritions FY 05 BOY Examiner Staff FY 05 Hiring FY 05 Attrits FY 06 Hiring Goal FY 06 hires (1/25/06) FY05 Hires as a Percent of Examiner Staffing in the TC 24%13%40%26%25%22%30%26% 20

Markush Practice

1.A cell adhesion protein of formula (1), A-(B)-(C)-(D) n -E or a pharmaceutically acceptable derivative thereof, wherein... Markush Practice 22

23

24

25

26

27

Production We Can Not Hire Our Way Out !!!

200, , , , , , , , , Without Strategic Plan 1,000 Hires & Lower Attrition Rate Plus Claims & Continuation Limits Plus Patentability Reports Historic Production 29

Contact Information John Doll Commissioner for Patents Phone:

John Doll – Commissioner for Patents February 1, 2006

Pendency Projections

Pendency Using FY 2005 Actual Filings at 8.1% 5050

5151

5252

5353

5454

Stats and Stuff

Total Continuation Filing Rates *Straight Continuations 37 CFR §1.53 (b)(1) – No Divisionals or CIPs – as of 1/17/06 56

Distribution of Independent Claims at Filing 0% 10% 20% 30% 40% 50% 1 2~34~6 7~10 11~ FY 2004FY

Distribution of Total Claims at Filing 0% 10% 20% 30% 40% 1~10 11~2021~2526~3031~4041~5051~60 61~ FY 2004FY

Total Claims at Filing and Issue FY 1990FY 1999FY ,000,000 6,000,000 9,000, Claims FiledClaims IssuedAverage Claims Filed 59

Distribution of the Number of References Cited in Applications ,000 1,500 2,000 2,500 3,000 3,500 None 1~34~5 6~10 11~2021~3031~40 >40 Sampling done April-June